Skip to main content
LLY
NYSE Life Sciences

Lilly Inks Two Asia Partnerships with $4.3B Potential, Continues Acquisition Spree

Tom Rudovsky · Reported by dpa-AFX
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1,077.285
Mkt Cap
$1.015T
52W Low
$623.78
52W High
$1,149.1
52W Position info
73% above low
Off High info
6.2% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

LLY sits 73% above its 52-week low of $623.78 on light trading volume (0.4× avg).

Summary

Eli Lilly announced two new strategic licensing deals today: a collaboration with Haisco Pharmaceutical Group with up to $2.97 billion in potential milestones, and a global licensing deal with Hanmi Pharmaceutical for Sonefpeglutide with up to $1.185 billion in potential milestones. These partnerships, totaling over $4.3 billion in potential value, expand Lilly's metabolic and autoimmune pipeline. This follows three infectious disease acquisitions announced last week with combined potential values exceeding $3.8 billion, highlighting Lilly's aggressive strategy to expand its pipeline across high-need areas.

At the time of this announcement, LLY was trading at $1,077.29 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1T. The 52-week trading range was $623.78 to $1,149.10. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: dpa-AFX.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 04, 2026, 1:53 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,416.54
Real-time Price: $1,366.76 info
Change: -$49.78 (-4%) info
Market Cap: $1.284T info
LLY
Oct 29, 2026, 3:21 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1,368.10
Real-time Price: $1,366.76 info
Change: -$1.34 (-0.10%) info
Market Cap: $1.284T info
LLY
Oct 29, 2026, 12:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1,370.30
Real-time Price: $1,366.76 info
Change: -$3.54 (-0.26%) info
Market Cap: $1.284T info
LLY
Oct 29, 2026, 11:35 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1,363.50
Real-time Price: $1,366.76 info
Change: +$3.26 (+0.24%) info
Market Cap: $1.284T info
LLY
Oct 29, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1,344.00
Real-time Price: $1,366.76 info
Change: +$22.76 (+2%) info
Market Cap: $1.284T info